Publication

The novel GLP-1-gastrin dual agonist ZP3022 improves glucose homeostasis and increases β-cell mass without affecting islet number in db/db mice

The Journal of Pharmacology and Experimental Therapeutics 350(2):353–360, 2014

Dalbøge LS, Almholt DL, Neerup TS, Vrang N, Jelsing J, Fosgerau K.

Share this page

Resource Library

Related resources

The IL-1β receptor antagonist SER140 postpones the onset of diabetes in female nonobese diabetic mice

The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach

Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides

Half-Life extending modifications of peptide YY3-36 direct receptor-mediated internalization

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650